MGL2⁺ Dermal Dendritic Cells Are Sufficient to Initiate Contact Hypersensitivity In Vivo

• Yosuke Kumamoto,

  Current address: Department of Immunobiology, Yale University School of Medicine, New Haven, Connecticut, United States of America

  Affiliation Laboratory of Cancer Biology and Molecular Immunology, Graduate School of Pharmaceutical Sciences, the University of Tokyo, Tokyo, Japan

  ⨯
• Kaori Denda-Nagai,

  Affiliation Laboratory of Cancer Biology and Molecular Immunology, Graduate School of Pharmaceutical Sciences, the University of Tokyo, Tokyo, Japan

  ⨯
• Satoshi Aida,

  Affiliation Laboratory of Cancer Biology and Molecular Immunology, Graduate School of Pharmaceutical Sciences, the University of Tokyo, Tokyo, Japan

  ⨯
• Nobuaki Higashi,

  Affiliation Laboratory of Cancer Biology and Molecular Immunology, Graduate School of Pharmaceutical Sciences, the University of Tokyo, Tokyo, Japan

  ⨯
• Tatsuro Irimura

  * E-mail: irimura@mol.f.u-tokyo.ac.jp

  Affiliation Laboratory of Cancer Biology and Molecular Immunology, Graduate School of Pharmaceutical Sciences, the University of Tokyo, Tokyo, Japan

  ⨯